This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 Aug;29(8):293-8.

Striving for standards in bioequivalence assessment: a review

H U Schulz¹, V W Steinijans

Affiliations

PMID: 1743802

Review

Striving for standards in bioequivalence assessment: a review

H U Schulz et al. Int J Clin Pharmacol Ther Toxicol. 1991 Aug.

. 1991 Aug;29(8):293-8.

Authors

H U Schulz¹, V W Steinijans

Affiliation

¹ Department of Angiology and Geriatrics, Medical University of Lübeck, Germany.

PMID: 1743802

No abstract available

PubMed Disclaimer

Similar articles

Generic bioequivalence: a scientific consensus needed.
[No authors listed] [No authors listed] Am Fam Physician. 1987 Feb;35(2):91, 95. Am Fam Physician. 1987. PMID: 3812175 No abstract available.
Generic vs. brand name drugs--defining and enforcing standards.
Lasagna LC. Lasagna LC. Internist. 1979 May;20(4):11, 13. Internist. 1979. PMID: 10316827 No abstract available.
Determining drug equality.
Hecht A. Hecht A. FDA Consum. 1975 Nov;9(9):18-20. FDA Consum. 1975. PMID: 10316633 No abstract available.
Striving for standards in bioequivalence assessment: a review.
Schulz HU, Steinijans VW. Schulz HU, et al. Int J Clin Pharmacol Ther Toxicol. 1992;30 Suppl 1:S1-6. Int J Clin Pharmacol Ther Toxicol. 1992. PMID: 1601528 Review. No abstract available.
Novel methods to assess bioequivalence.
Karalis V, Symillides M, Macheras P. Karalis V, et al. Expert Opin Drug Metab Toxicol. 2011 Jan;7(1):79-88. doi: 10.1517/17425255.2011.539202. Epub 2010 Dec 1. Expert Opin Drug Metab Toxicol. 2011. PMID: 21118059 Review.

See all similar articles

Cited by

Clinical pharmacological equivalence of a novel FCH-free GTN spray with low ethanol content vs a FCH-containing GTN spray.
de Mey C, Erb K, Zimmermann T, Mutschler H, Blume H, Belz GG. de Mey C, et al. Eur J Clin Pharmacol. 1995;47(5):437-43. doi: 10.1007/BF00196858. Eur J Clin Pharmacol. 1995. PMID: 7720766 Clinical Trial.
Controversies in bioequivalence studies.
Steinijans VW, Hauschke D, Jonkman JH. Steinijans VW, et al. Clin Pharmacokinet. 1992 Apr;22(4):247-53. doi: 10.2165/00003088-199222040-00001. Clin Pharmacokinet. 1992. PMID: 1606785 Review. No abstract available.
Bioequivalence testing of a new tablet formulation of generic fluoxetine.
Jovanović D, Kilibarda V, Dordević S, Jovanović M, Jovic-Stosić J, Srdić D, Knezević T. Jovanović D, et al. Eur J Drug Metab Pharmacokinet. 2006 Jan-Mar;31(1):35-40. doi: 10.1007/BF03190640. Eur J Drug Metab Pharmacokinet. 2006. PMID: 16715781 Clinical Trial.
Metrics for the evaluation of bioequivalence of modified-release formulations.
Endrenyi L, Tothfalusi L. Endrenyi L, et al. AAPS J. 2012 Dec;14(4):813-9. doi: 10.1208/s12248-012-9396-8. Epub 2012 Aug 22. AAPS J. 2012. PMID: 22910857 Free PMC article. Review.
A survey of the likelihood approach to bioequivalence trials.
Choi L, Caffo B, Rohde C. Choi L, et al. Stat Med. 2008 Oct 30;27(24):4874-94. doi: 10.1002/sim.3334. Stat Med. 2008. PMID: 18618422 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information